{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "33526866",
  "DateCompleted": {
    "Year": "2021",
    "Month": "04",
    "Day": "22"
  },
  "DateRevised": {
    "Year": "2022",
    "Month": "10",
    "Day": "27"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2021",
        "Month": "02",
        "Day": "02"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1038/s41416-021-01262-8"
    ],
    "Journal": {
      "ISSN": "1532-1827",
      "JournalIssue": {
        "Volume": "124",
        "Issue": "8",
        "PubDate": {
          "Year": "2021",
          "Month": "Apr"
        }
      },
      "Title": "British journal of cancer",
      "ISOAbbreviation": "Br J Cancer"
    },
    "ArticleTitle": "The impact of COVID-19 on systemic anticancer treatment delivery in Scotland.",
    "Pagination": {
      "StartPage": "1353",
      "EndPage": "1356",
      "MedlinePgn": "1353-1356"
    },
    "Abstract": {
      "AbstractText": [
        "Understanding the impact of the COVID-19 pandemic on systemic anticancer therapy delivery (SACT) is crucial to appreciate the short- and long-term consequences for cancer patients and plan future care. Here, we report real-time national SACT delivery data from NHS Scotland. We demonstrate an initial rapid reduction in patient attendance of 28.7% with subsequent rapid recovery following service redesign. The smallest decrease was seen in breast cancer (19.7%), which also had the most rapid recovery and the largest decrease seen in colorectal cancer (43.4%). Regional variation in the magnitude of impact on SACT delivery was observed, but nadirs occurred at the same time and the rate of recovery was similar across all regions. This recovery reflected a coordinated national approach and associated patient and clinician support structures, which facilitated the creation of COVID-19-protected areas for SACT delivery in Scottish cancer centres enabling rapid sharing of successful and innovative strategies. The data show that these actions have limited the disadvantage to cancer patients."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [
          "0000-0002-5773-8650"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Division of Molecular and Clinical Medicine, Ninewells Hospital and Medical School, University of Dundee, Dundee, UK."
          },
          {
            "Identifier": [],
            "Affiliation": "Tayside Cancer Centre, Ninewells Hospital and Medical School, NHS Tayside, Dundee, UK."
          }
        ],
        "LastName": "Baxter",
        "ForeName": "Mark A",
        "Initials": "MA"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "NHS Lanarkshire, South Lanarkshire, UK."
          }
        ],
        "LastName": "Murphy",
        "ForeName": "John",
        "Initials": "J"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Edinburgh Cancer Research Centre, University of Edinburgh, Edinburgh, UK."
          },
          {
            "Identifier": [],
            "Affiliation": "Edinburgh Cancer Centre, NHS Lothian, Edinburgh, UK."
          }
        ],
        "LastName": "Cameron",
        "ForeName": "David",
        "Initials": "D"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "NHS Grampian, Aberdeen, UK."
          }
        ],
        "LastName": "Jordan",
        "ForeName": "Judith",
        "Initials": "J"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "West of Scotland Cancer Network, Glasgow, UK."
          }
        ],
        "LastName": "Crearie",
        "ForeName": "Christine",
        "Initials": "C"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Edinburgh Cancer Centre, NHS Lothian, Edinburgh, UK."
          }
        ],
        "LastName": "Lilley",
        "ForeName": "Christina",
        "Initials": "C"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "West of Scotland Cancer Network, Glasgow, UK."
          }
        ],
        "LastName": "Sadozye",
        "ForeName": "Azmat",
        "Initials": "A"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "West of Scotland Cancer Network, Glasgow, UK."
          }
        ],
        "LastName": "Maclean",
        "ForeName": "Mary",
        "Initials": "M"
      },
      {
        "Identifier": [
          "0000-0001-6015-7841"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Edinburgh Cancer Research Centre, University of Edinburgh, Edinburgh, UK."
          },
          {
            "Identifier": [],
            "Affiliation": "Edinburgh Cancer Centre, NHS Lothian, Edinburgh, UK."
          }
        ],
        "LastName": "Hall",
        "ForeName": "Peter",
        "Initials": "P"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Tayside Cancer Centre, Ninewells Hospital and Medical School, NHS Tayside, Dundee, UK."
          }
        ],
        "LastName": "Phillips",
        "ForeName": "Angela",
        "Initials": "A"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "NHS Grampian, Aberdeen, UK."
          }
        ],
        "LastName": "Greger",
        "ForeName": "Alex",
        "Initials": "A"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "NHS Highland, Inverness, UK."
          }
        ],
        "LastName": "Madeleine",
        "ForeName": "Jude",
        "Initials": "J"
      },
      {
        "Identifier": [
          "0000-0003-2055-4572"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Division of Molecular and Clinical Medicine, Ninewells Hospital and Medical School, University of Dundee, Dundee, UK. r.petty@dundee.ac.uk."
          },
          {
            "Identifier": [],
            "Affiliation": "Tayside Cancer Centre, Ninewells Hospital and Medical School, NHS Tayside, Dundee, UK. r.petty@dundee.ac.uk."
          }
        ],
        "LastName": "Petty",
        "ForeName": "Russell D",
        "Initials": "RD"
      }
    ],
    "GrantList": [
      {
        "GrantID": "CAF/20/01",
        "Acronym": "CSO_",
        "Agency": "Chief Scientist Office",
        "Country": "United Kingdom"
      }
    ],
    "PublicationTypeList": [
      "Journal Article"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "England",
    "MedlineTA": "Br J Cancer",
    "NlmUniqueID": "0370635",
    "ISSNLinking": "0007-0920"
  },
  "CommentsCorrectionsList": [
    {
      "RefSource": "Br J Cancer. 2021 Mar 15;:",
      "PMID": "33723400"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "complications",
        "epidemiology",
        "therapy",
        "virology"
      ],
      "DescriptorName": "COVID-19"
    },
    {
      "QualifierName": [
        "complications",
        "epidemiology",
        "therapy",
        "virology"
      ],
      "DescriptorName": "Colorectal Neoplasms"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Female"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Male"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Pandemics"
    },
    {
      "QualifierName": [
        "genetics",
        "pathogenicity"
      ],
      "DescriptorName": "SARS-CoV-2"
    },
    {
      "QualifierName": [
        "epidemiology"
      ],
      "DescriptorName": "Scotland"
    }
  ],
  "CoiStatement": "R.D.P. has undertaken speaking, consulting and advisory roles for Eli Lilly, BMS, Pfizer, Sanofi, Servier, and received research funding (not related to the work in this manuscript) from Astra Zeneca, Roche, MSD, Merck Serrano, Eli Lilly, Five Prime Therapeutics, Clovis, Boston Biomedical and Janssen."
}